Andere Sprachen Willow Biosciences Inc.

Aktien

A2PK2F

CA97111B4047

WLLW

Schlusskurs Toronto S.E. Andere Börsenplätze 00:00:00 26.06.2024			% 5 Tage	% 1. Jan.
0,105 ^CAD	-4,55 %		0,00 %	+5,00 %

26.06.	Willow Biosciences gibt Unternehmens-Update und schließt neues Partnerprogramm ab	MT
30.05.	Willow Biosciences Inc. kündigt Multi-Produkt Entwicklungs- und Lizenzierungspartnerschaft mit Laurus Labs an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Willow Biosciences Provides Corporate Update and Signs New Partnered Program	26.06.
Willow Biosciences Brief: Announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients	26.06.
Willow Biosciences Brief: Expanding into the high growth biopesticide sector with addition of new partnered program	26.06.
Willow Biosciences Brief: Announces its first patent being issued; Anticipates filing another five patents in 2024 primarily related to its steroid production platform	26.06.
Willow Biosciences Brief: Anticipates revenue of over $1.0 million in Q2, and over $3.5 million for 2024 on existing programs	26.06.
Willow Biosciences Brief: Providing Corporate Update and Signs New Partnered Program	26.06.
WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM	26.06.
Willow Bioscience Announces 3 Million dollar Fundraising to Support Partnership with Laurus Labs	07.06.
Willow Biosciences to Raise Up to $3 Million Via Brokered Private Placement; Shares Jumped 24% on Friday	03.06.
Willow Biosciences Brief: Announcing Brokered Private Placement Offering To Raise Up To $3 Million	03.06.
WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION	03.06.
Willow Biosciences Inc. announced that it expects to receive CAD 3 million in funding	03.06.
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab	30.05.
Willow Biosciences Brief: Announcing Multi-product Development and Licensing Partnership With Laurus Lab	30.05.
Willow Biosciences Inc. Announces Multi-Product Development and Licensing Partnership with Laurus Labs	30.05.
WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS	30.05.
Willow Biosciences Brief: Reiterating its Expectations of at least doubling its full year 2024 revenues, As Reports Q1 Results	13.05.
Willow Biosciences Inc. Provides Earnings Guidance for the Fiscal Year 2024	13.05.
Willow Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13.05.
Willow Biosciences Narrows 2023 Loss YOY	01.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Willow Biosciences Inc.

Aktien

A2PK2F

CA97111B4047

WLLW

Andere Sprachen

Filter